Roberto Rodríguez‐Ibeas

509 total citations
29 papers, 309 citations indexed

About

Roberto Rodríguez‐Ibeas is a scholar working on Economics and Econometrics, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Roberto Rodríguez‐Ibeas has authored 29 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Economics and Econometrics, 5 papers in General Health Professions and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Roberto Rodríguez‐Ibeas's work include Health Systems, Economic Evaluations, Quality of Life (11 papers), Pharmaceutical Economics and Policy (11 papers) and Healthcare Policy and Management (5 papers). Roberto Rodríguez‐Ibeas is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (11 papers), Pharmaceutical Economics and Policy (11 papers) and Healthcare Policy and Management (5 papers). Roberto Rodríguez‐Ibeas collaborates with scholars based in Spain, Netherlands and Chile. Roberto Rodríguez‐Ibeas's co-authors include Fernando Antoñanzas, Antoinette D. I. van Asselt, Maarten J. Postma, Marino González, Pere Esteban, Marc Prohom and Mariano Barriendos i Vallvé and has published in prestigious journals such as Health Economics, Value in Health and PharmacoEconomics.

In The Last Decade

Roberto Rodríguez‐Ibeas

28 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Rodríguez‐Ibeas Spain 11 207 42 36 31 28 29 309
David B. Ridley United States 13 411 2.0× 25 0.6× 34 0.9× 79 2.5× 32 1.1× 39 546
Brett Wendling United States 9 207 1.0× 37 0.9× 125 3.5× 26 0.8× 18 0.6× 17 377
Christoph Schwierz Belgium 10 249 1.2× 6 0.1× 117 3.3× 40 1.3× 17 0.6× 22 368
Ana Xavier Portugal 7 232 1.1× 6 0.1× 35 1.0× 40 1.3× 33 1.2× 12 359
Eli Liebman United States 9 157 0.8× 31 0.7× 117 3.3× 15 0.5× 21 0.8× 21 301
Farzad Peiravian Iran 10 112 0.5× 3 0.1× 33 0.9× 29 0.9× 34 1.2× 53 271
Marta Wosińska United States 5 233 1.1× 72 1.7× 23 0.6× 167 5.4× 33 1.2× 10 357
Nina Zimmermann Austria 10 341 1.6× 4 0.1× 68 1.9× 87 2.8× 7 0.3× 38 401
Claudia Habl Austria 11 264 1.3× 3 0.1× 49 1.4× 66 2.1× 7 0.3× 41 380
Szymon Jarosławski France 9 127 0.6× 4 0.1× 47 1.3× 12 0.4× 11 0.4× 23 335

Countries citing papers authored by Roberto Rodríguez‐Ibeas

Since Specialization
Citations

This map shows the geographic impact of Roberto Rodríguez‐Ibeas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Rodríguez‐Ibeas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Rodríguez‐Ibeas more than expected).

Fields of papers citing papers by Roberto Rodríguez‐Ibeas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Rodríguez‐Ibeas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Rodríguez‐Ibeas. The network helps show where Roberto Rodríguez‐Ibeas may publish in the future.

Co-authorship network of co-authors of Roberto Rodríguez‐Ibeas

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Rodríguez‐Ibeas. A scholar is included among the top collaborators of Roberto Rodríguez‐Ibeas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Rodríguez‐Ibeas. Roberto Rodríguez‐Ibeas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodríguez‐Ibeas, Roberto, et al.. (2024). Simple economics of vaccination: public policies and incentives. International Journal of Health Economics and Management. 24(2). 155–172. 2 indexed citations
2.
Asselt, Antoinette D. I. van, et al.. (2021). Diagnostic Testing for Sepsis: A Systematic Review of Economic Evaluations. Antibiotics. 11(1). 27–27. 5 indexed citations
3.
Asselt, Antoinette D. I. van, et al.. (2021). Efficiency of Diagnostic Testing for Helicobacter pylori Infections—A Systematic Review. Antibiotics. 10(1). 55–55. 6 indexed citations
4.
Antoñanzas, Fernando, et al.. (2021). Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model. Health Economics Review. 11(1). 29–29. 12 indexed citations
5.
Antoñanzas, Fernando, et al.. (2019). Pre-approval incentives to promote adoption of personalized medicine: a theoretical approach. Health Economics Review. 9(1). 28–28. 5 indexed citations
6.
Antoñanzas, Fernando, et al.. (2019). Implementation of risk-sharing contracts as perceived by Spanish hospital pharmacists. Health Economics Review. 9(1). 25–25. 8 indexed citations
7.
Antoñanzas, Fernando, et al.. (2019). The Use of Risk-Sharing Contracts in Healthcare: Theoretical and Empirical Assessments. PharmacoEconomics. 37(12). 1469–1483. 39 indexed citations
8.
Antoñanzas, Fernando, et al.. (2018). Personalized Medicine and Pay for Performance: Should Pharmaceutical Firms be Fully Penalized when Treatment Fails?. PharmacoEconomics. 36(7). 733–743. 13 indexed citations
9.
Antoñanzas, Fernando, et al.. (2017). Endogenous versus exogenous generic reference pricing for pharmaceuticals. International Journal of Health Economics and Management. 17(4). 413–432. 2 indexed citations
10.
Antoñanzas, Fernando, et al.. (2016). Implementing personalized medicine with asymmetric information on prevalence rates. Health Economics Review. 6(1). 35–35. 3 indexed citations
11.
Antoñanzas, Fernando, et al.. (2014). Impacto del Real Decreto-Ley 16/2012 sobre el copago farmacéutico en el número de recetas y en el gasto farmacéutico. Revista Española de Salud Pública. 88(2). 233–249. 11 indexed citations
12.
Antoñanzas, Fernando, et al.. (2014). Some economics on personalized and predictive medicine. The European Journal of Health Economics. 16(9). 985–994. 14 indexed citations
13.
Antoñanzas, Fernando, et al.. (2014). Should the patent system for pharmaceuticals be replaced? A theoretical approach. Expert Review of Pharmacoeconomics & Outcomes Research. 14(5). 617–626. 2 indexed citations
14.
Rodríguez‐Ibeas, Roberto, et al.. (2013). Methodological reviews of economic evaluations in health care: what do they target?. The European Journal of Health Economics. 15(8). 829–840. 12 indexed citations
15.
Antoñanzas, Fernando, et al.. (2011). Genetic testing in the European Union: does economic evaluation matter?. The European Journal of Health Economics. 13(5). 651–661. 11 indexed citations
16.
Antoñanzas, Fernando & Roberto Rodríguez‐Ibeas. (2011). Healthy vs. unhealthy food: a strategic choice for firms and consumers. Health Economics Review. 1(1). 4–4. 5 indexed citations
17.
Antoñanzas, Fernando, et al.. (2011). Should health authorities offer risk-sharing contracts to pharmaceutical firms? A theoretical approach. Health Economics Policy and Law. 6(3). 391–403. 36 indexed citations
18.
19.
20.
Rodríguez‐Ibeas, Roberto. (2002). Regulatory Enforcement with Discretionary Fining and Litigation. Bulletin of Economic Research. 54(2). 105–118. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David B. Ridley Breakdown of academic impact, for papers by Brett Wendling Breakdown of academic impact, for papers by Christoph Schwierz Breakdown of academic impact, for papers by Ana Xavier Breakdown of academic impact, for papers by Eli Liebman Breakdown of academic impact, for papers by Farzad Peiravian Breakdown of academic impact, for papers by Marta Wosińska Breakdown of academic impact, for papers by Nina Zimmermann Breakdown of academic impact, for papers by Claudia Habl Breakdown of academic impact, for papers by Szymon Jarosławski
Rankless by CCL
2026